Skip to content

A prospective cohort study to evaluate the efficacy of adjuvant chemotherapy after curative resection in patients with intrahepatic cholangiocarcinoma

Prospective cohort study of biliary tract cancers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111087
Enrollment
Unknown
Registered
2025-10-24
Start date
2019-06-29
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary tract cancers

Interventions

Adjuvant chemotherapy (AC) group:None
Non-AC group:None

Sponsors

The First Affiliated Hospital with Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients with initially histologically confirmed intrahepatic cholangiocarcinoma after macroscopically complete resection (R0 or R1); 2. without any history of other malignant tumors; 3. ECOG scores = 18 years old, both male and female are eligible.

Exclusion criteria

Exclusion criteria: 1. Patients who had a palliative surgery, had extrahepatic metastasis or experienced recurrence within one month after surgery; 2. Those who died within one month or were lost to follow-up with no evidence of recurrence within 6 months after surgery; 3. Those who had other adjuvant therapy excluding chemotherapy.

Design outcomes

Primary

MeasureTime frame
Recurrence-free surival;

Secondary

MeasureTime frame
Overall survival;

Countries

China

Contacts

Public ContactLi Xiangcheng

The First Affiliated Hospital with Nanjing Medical University

drxcli@njmu.edu.cn+86 1895199088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026